Eieland Alexander K, Normann Kjersti R, Sundaram Arvind Y M, Nyman Tuula A, Øystese Kristin A B, Lekva Tove, Berg Jens P, Bollerslev Jens, Olarescu Nicoleta C
Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital (OUS), 0424 Oslo, Norway.
Research Institute for Internal Medicine, Oslo University Hospital (OUS), 0372 Oslo, Norway.
Cancers (Basel). 2020 Oct 14;12(10):2980. doi: 10.3390/cancers12102980.
Functioning (FCA) and silent corticotroph (SCA) pituitary adenomas act differently from a clinical perspective, despite both subtypes showing positive TBX19 (TPIT) and/or adrenocorticotropic hormone (ACTH) staining by immunohistochemistry. They are challenging to treat, the former due to functional ACTH production and consequently hypercortisolemia, and the latter due to invasive and recurrent behavior. Moreover, the molecular mechanisms behind their distinct behavior are not clear. We investigated global transcriptome and proteome changes in order to identify signaling pathways that can explain FCA and SCA differences (e.g., hormone production vs. aggressive growth). In the transcriptomic study, cluster analyses of differentially expressed genes revealed two distinct groups in accordance with clinical and histological classification. However, in the proteomic study, a greater degree of heterogeneity within the SCA group was found. Genes and proteins related to protein synthesis and vesicular transport were expressed by both adenoma groups, although different types and a distinct pattern of collagen/extracellular matrix proteins were presented by each group. Moreover, several genes related to endoplasmic reticulum protein processing were overexpressed in the FCA group. Together, our findings shed light on the different repertoires of activated signaling pathways in corticotroph adenomas, namely, the increased protein processing capacity of FCA and a specific pattern of adhesion molecules that may play a role in the aggressiveness of SCA.
功能性促肾上腺皮质激素细胞腺瘤(FCA)和静默性促肾上腺皮质激素细胞腺瘤(SCA)从临床角度来看表现不同,尽管这两种亚型通过免疫组织化学均显示TBX19(TPIT)和/或促肾上腺皮质激素(ACTH)染色呈阳性。它们的治疗具有挑战性,前者是由于功能性ACTH分泌以及随之而来的高皮质醇血症,后者则是由于侵袭性和复发性行为。此外,它们不同行为背后的分子机制尚不清楚。我们研究了整体转录组和蛋白质组的变化,以确定能够解释FCA和SCA差异的信号通路(例如,激素分泌与侵袭性生长)。在转录组学研究中,对差异表达基因的聚类分析根据临床和组织学分类揭示了两个不同的组。然而,在蛋白质组学研究中,发现SCA组内存在更大程度的异质性。两个腺瘤组均表达了与蛋白质合成和囊泡运输相关的基因和蛋白质,尽管每组呈现出不同类型和独特模式的胶原蛋白/细胞外基质蛋白。此外,FCA组中几个与内质网蛋白质加工相关的基因过表达。总之,我们的研究结果揭示了促肾上腺皮质激素细胞腺瘤中不同的激活信号通路,即FCA增加的蛋白质加工能力以及可能在SCA侵袭性中起作用的特定粘附分子模式。